Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
21 Jul 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-advisers-recommend-against-otsukas-ptsd-combination-treatment-2025-07-18/
17 Jul 2025
// FDA
17 Jul 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/otsuka-inks-613m-deal-swedish-biotechs-autoimmune-antibodies
23 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/harbour-biomed-enters-global-strategic-collaboration-with-otsuka-to-advance-bcmaxcd3-bispecific-t-cell-engagers-302487815.html
07 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250606873555/en/Otsuka-Sibeprenlimab-Phase-3-Data-Show-a-Statistically-Significant-and-Clinically-Meaningful-Proteinuria-Reduction-for-the-Treatment-of-Immunoglobulin-A-Nephropathy-IgAN
27 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250527959047/en/Otsuka-Announces-FDA-Acceptance-and-Priority-Review-of-Biologics-License-Application-BLA-for-Sibeprenlimab-in-the-Treatment-of-Immunoglobulin-A-Nephropathy-IgAN
ABOUT THIS PAGE
Otsuka Pharmaceutical is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of Aripiprazole bulk offered by Otsuka Pharmaceutical
Find a price of Brexpiprazole bulk offered by Otsuka Pharmaceutical
Find a price of Tolvaptan bulk offered by Otsuka Pharmaceutical
Find a price of Tolbaptan SD Powder bulk offered by Otsuka Pharmaceutical